Roche Media 17. März 2026 Roche Expands AI Computing Power with Over 2,100 Nvidia Chips to Accelerate Drug Development - CXO Digitalpulse
Roche Media 16. März 2026 Roche inks Nvidia deal to bolster AI factory, speed up drug and diagnostic development - Fierce Biotech
Roche Media 16. März 2026 Pharmaceutical company Roche deploys 3,500 Nvidia Blackwell GPUs across hybrid cloud and on‐premises - Data Center Dynamics
Roche Media 10. März 2026 Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead - Fierce Biotech
Roche Media 9. März 2026 Roche’s oral SERD flunks phase 3 trial in 1st-line breast cancer, raising questions of mechanism's limits - Fierce Biotech
Roche Media 9. März 2026 Roche’s prized breast cancer pill fails closely watched study - BioPharma Dive
Roche Media 9. März 2026 ZAWYA-PRESSR: Ministry of Health and Population and Roche Diagnostics sign MoU to advance digital pathology in Egypt - TradingView
Roche Media 6. März 2026 Roche, Zealand tout the tolerability of their amylin obesity drug - TechTarget
Roche Media 6. März 2026 Roche’s petrelintide shows promise in Phase II obesity trial - The Pharma Letter
Roche Media 5. März 2026 Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug - Fierce Biotech
Roche Media 5. März 2026 Roche, stakeholders urge Africa to treat health as economic investment - Realnews Magazine
Roche Media 4. März 2026 Roche announces $481m investment in South Korean biotech sector - Investment Monitor
Roche Media 4. März 2026 Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem' - Fierce Biotech
Roche Media 4. März 2026 Roche to invest $478 million in Korea clinical trials over 5 years - koreabiomed.com
Roche Media 4. März 2026 Roche to invest $481 mn in South Korea clinical trials, biotech partnerships - The Korea Economic Daily Global Edition